Tablets & Capsules

TC0720

Issue link: https://www.e-digitaleditions.com/i/1267517

Contents of this Issue

Navigation

Page 21 of 59

20 July 2020 Tablets & Capsules S This article describes how technological advances have made plant-based hard-capsules an attractive alternative to tradi- tional gelatin hard capsules, offering enhanced technical and cultural compatibility and allowing formulators to develop innovative patient-centric medicines. olid oral dosage forms (SODFs) are patients' preferred way to take medications. According to a 2017 Kiplinger report, eight of the 15 all-time top-selling drug prod- ucts are SODFs, including the number one top seller [1]. While the number of parenterally administered biologic drug products has been increasing, many patients find injections painful, stressful, and inconvenient. SODFs remain the preferred method of deliver- ing active pharmaceutical ingredients (APIs) for drug Julien Lamps Lonza Plant-based hard capsules: A new era for patients and drug developers capsules

Articles in this issue

Archives of this issue

view archives of Tablets & Capsules - TC0720